Exosome Delivery of miRNAs for Cardiac Fibroblast Reprogramming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering reprogramming factors to cardiac tissue, such as viruses, face challenges like limited cell specificity and packaging size constraints, hindering the effective conversion of scar fibroblasts into cardiomyocytes for improving cardiac function after injury.
Innovation Solution
The use of loaded exosomes isolated from endothelial cells, specifically C166 cells, which contain exogenous miRNAs like miR148a-3p, to target and reprogram cardiac fibroblasts, enhancing the conversion of fibroblasts into cardiomyocytes and improving cardiac function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If viral delivery methods are used to deliver reprogramming factors to cardiac tissue, then delivery capability is achieved, but cell specificity is poor and packaging size is constrained
Solution Approach 1:
The patent uses exosomes as intermediary carriers to deliver reprogramming factors to cardiac fibroblasts. Exosomes are small extracellular vesicles that naturally mediate intercellular communication and can be engineered to deliver specific miRNAs with high cell specificity, avoiding the packaging constraints and lack of specificity associated with viral delivery methods
Solution Approach 2:
The patent changes the delivery vehicle from viruses to exosomes, fundamentally altering the carrier parameters. This switch enables smaller packaging capacity (avoiding viral constraints) while achieving higher cell specificity through exosome's natural targeting mechanisms and surface protein composition
2Productivity
If viral delivery is used for reprogramming factors, then delivery is achieved, but reprogramming efficiency is limited
Solution Approach 1:
The patent leverages the self-service capability of exosomes by utilizing their natural cellular uptake mechanisms. Exosomes are endogenously produced and naturally internalized by target cells through endocytosis, eliminating the need for complex viral entry mechanisms and achieving more reliable and efficient reprogramming delivery
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
C166-derived exosomes efficiently deliver reprogramming factors, achieving significant improvements in cardiac function by converting approximately 20% of cardiac fibroblasts into cardiomyocytes in the infarct border zone, surpassing the efficacy of traditional viral delivery methods.
Implementation Method 1
a loaded exosome comprising an exosome isolated from an endothelial cell and at least one exogenous miR comprised within the exosome
Data Source
AI summary
The present disclosure describes, in part, exosomes comprising miRNA for the reprogramming of fibroblasts and methods of using the same.